一种新的脉冲调节闭环人工胰腺,基于静脉注射胰岛素和葡萄糖
Simon L Goede1, Victor H Snels2, Willem-Jan W J H Berghuis3
1, Lochem, The Netherlands. slgoede@kpnmail.nl.
Scientific reports
|November 4, 2024
概括
这项研究介绍了一种电子胰腺,模仿自然胰岛素和葡萄糖分泌. 该设备为糖尿病患者提供了改进的自动血糖控制,克服了当前系统的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 内分泌学 在内分泌学.
- 糖尿病 技术 技术
背景情况:
- 目前用于糖尿病管理的自动化胰岛素输送系统由于皮下胰岛素吸收的变化而存在局限性.
- 在现有的半循环和闭环系统中,低于最佳的葡萄糖控制和用户干预的需要是常见的.
- 模仿自然胰腺复杂的激素调节仍然是一个挑战.
研究的目的:
- 将正常胰腺的内分泌生理转化为电子控制系统.
- 开发一种能够自动保持最佳euglycemic (正常血糖) 条件的设备.
- 通过静脉输送模拟生理脉动性胰岛素和葡萄糖的使用.
主要方法:
- 使用标准电子元件开发正常内分泌胰腺的电子等价物.
- 模拟直接静脉脉动性胰岛素和葡萄糖的静脉注射.
- 控制系统旨在模仿健康个体的生理观察.
主要成果:
- 开发的电子系统成功地翻译了胰腺内分泌功能.
- 该设备模拟生理脉动性胰岛素和葡萄糖的输送.
- 该系统旨在广泛适用于个人和条件.
结论:
- 这种电子胰腺为糖尿病患者的自动葡萄糖平衡管理提供了一种新的方法.
- 这种脉动性静脉注射系统克服了皮下注射方法的局限性.
- 该设备有可能为所有糖尿病患者改善,自动控制euglycemic.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Glucagon-like Receptor Agonists
300
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
300
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Insulin: Dosing Regimen and Adverse Effects
146
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
146
Insulin: Biosynthesis, Chemistry, and Preparation
359
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
359
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K


